[Asia Economy Reporter Oh Ju-yeon] Pharmicell announced on the 7th that it has signed a supply contract for pharmaceutical intermediates mPEGs worth 997.65 million KRW with the US company Nektar Therapeutics. This corresponds to 3.07% of recent sales revenue.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
